Liuweizhiji Gegen-Sangshen beverage protects against alcoholic liver disease in mice through the gut microbiota mediated SCFAs/GPR43/GLP-1 pathway. [PDF]
Tang M+14 more
europepmc +1 more source
Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics. [PDF]
Yang J, Zhuang Q, Tang K, Liu X.
europepmc +1 more source
Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease. [PDF]
Ichikawa T+12 more
europepmc +1 more source
Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease. [PDF]
Swanson GR+3 more
europepmc +1 more source
Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease. [PDF]
Yeung MW+5 more
europepmc +1 more source
Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota. [PDF]
Wei S+19 more
europepmc +1 more source
Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis. [PDF]
Xiong SY, Wu GS, Li C, Ma W, Luo HR.
europepmc +1 more source
Comparison of Protective Effects of Polyphenol-Enriched Extracts from Thinned Immature Kiwifruits and Mature Kiwifruits against Alcoholic Liver Disease in Mice. [PDF]
Deng W+9 more
europepmc +1 more source
IL-37d suppresses Rheb-mTORC1 axis independently of TCS2 to alleviate alcoholic liver disease. [PDF]
Chen N+13 more
europepmc +1 more source